Fusion PET-CT detection of neurolymphomatosis originating from primary breast lymphoma: A case report and literature review
- Authors:
- Liying Xu
- Yunfeng Zhou
- Dasheng Qiu
- Salman Shams
View Affiliations
Affiliations: Department of Radiology, Zhongnan Hospital of Wuhan University, Wuhan 430071, P.R. China, Department of Oncology, Zhongnan Hospital of Wuhan University, Wuhan 430071, P.R. China, Department of PET/CT, Hubei Cancer Hospital, Wuhan 430079, P.R. China, Department of Radiology, Zhongnan Hospital of Wuhan University, Wuhan 430071, P.R. China
- Published online on: August 3, 2012 https://doi.org/10.3892/ol.2012.840
-
Pages:
973-975
Metrics: Total
Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
This article is mentioned in:
Abstract
Neurolymphomatosis (NL) is an extremely rare manifestation. Involvement of the cranial and peripheral nerves is an unusual manifestation of NL which is occasionally difficult to diagnose using conventional imaging modalities. A 45-year-old female in complete remission from primary breast lymphoma presented with multiple neurological symptoms. 18F-FDG PET/CT revealed multiple nodular hypermetabolic lesions along the cranial and peripheral nerves, which corresponded to the patient's neurological symptoms. These findings suggest that 18F-FDG PET/CT successfully detects the infiltration of cranial and peripheral nerves by lymphoma.
View References
|
1.
|
HS MasonV JohariDE MarchGM CrisiPrimary
breast lymphoma: radiologic and pathologic findingsBreast
J11495496200510.1111/j.1075-122X.2005.00167.x16297110
|
|
2.
|
S GrisariuB AvniTT
BatchelorNeurolymphomatosis: an International Primary CNS Lymphoma
Collaborative Group
reportBlood11550055011201010.1182/blood-2009-12-25821020368468
|
|
3.
|
S KahramanH SabuncuogluO GunhanMA GursesS
SirinA rare reason of foot drop caused by primary diffuse large
b-cell lymphoma of the sciatic nerve: case reportActa Neurochir
(Wien)152125128201010.1007/s00701-009-0339-919415174
|
|
4.
|
V StefoniA BroccoliC PellegriniE
DerenziniM FinaPL ZinzaniCNS recurrence of primary mediastinal
large b-cell lymphoma after complete remissionJ
Neurooncol95135139200910.1007/s11060-009-9898-019381440
|
|
5.
|
MJ van den BentHG de BruinGM BosG Brutel
de la RivièrePA Sillevis SmittNegative sural nerve biopsy in
neurolymphomatosisJ Neurol24611591163199910653308
|
|
6.
|
FM PaesDG KalkanisPA SiderasAN SerafiniFDG
PET/CT of extranodal involvement in non-Hodgkin lymphoma and
Hodgkin
diseaseRadiographics30269291201010.1148/rg.30109508820083598
|
|
7.
|
H PalmedoH UrbachH BenderFDG-PET in
immunocompetent patients with primary central nervous system
lymphoma: correlation with MRI and clinical follow-upEur J Nucl Med
Mol Imaging33164168200610.1007/s00259-005-1917-616220304
|
|
8.
|
E Even-SapirG LievshitzC PerryY HerishanuH
LermanU MetserFluorine-18 fluorodeoxyglucose PET/CT patterns of
extranodal involvement in patients with Non-Hodgkin lymphoma and
Hodgkin’s diseaseRadiol Clin North Am45697709vii2007
|
|
9.
|
CM HongS-W LeeHJ LeeNeurolymphomatosis on
F-18 FDG PET/CT and MRI findings: A case reportNucl Med Mol
Imaging457678201110.1007/s13139-010-0070-824899982
|
|
10.
|
Y BronsteinS TummalaE RohrenF-18 FDG
PET/CT for detection of malignant involvement of peripheral nerves:
case series and literature reviewClin Nucl
Med3696100201110.1097/RLU.0b013e318203bb0e21220969
|
